AI-Integrated Virtual Reality Speech Therapy in Children With Speech Sound Disorders

Speech sound disorders can affect intelligibility, learning, participation, and communication in children. This completed randomized controlled trial evaluated AI-Integrated Virtual Reality Speech Therapy (AI-IVR-ST) against conventional speech therapy in children aged 5 to 12 years with articulation and/or phonological disorders. Sixty-four children were randomized equally to two groups and received treatment three times per week for 12 weeks. The principal efficacy outcome was Percentage of Consonants Correct (PCC). Additional outcomes included GFTA-3, PPVT-4, therapy engagement and adherence, FACES III, and ASHA NOMS.